Objective: To research the impact of remote home rehabilitation in the COVID-19 epidemic situation for individuals with chronic obstructive pulmonary disease (COPD). Methods: Over the course of the COVID-19 pandemic, 74 patients with stable COPD were randomly assigned to either a control group (n = 37) or a faraway group (n = 37). The control group got normal pulmonary rehabilitation in the outpatient setting, which included exercise and self-management instruction for 8 weeks, whereas the experimental group engaged in in-home rehabilitation for 8 weeks under the supervision of physiotherapists. Six-minute walking distance (6MWD), quality of life, physical activity, and self-efficacy were measured before the intervention, 8 weeks after the intervention, and again 6 months after the intervention for both groups. Results: After 8 weeks of intervention, there was no significant difference between the remote and control groups with respect to 6MWD, quality of life, or self-efficacy. After 6 months, the remote group's 6MWD was much higher than the control group's. This was the result of the 8-week intervention. Conclusion: Patients with COPD during the COVID-19 epidemic can benefit from remote home therapy in the same way as they would from traditional outpatient pulmonary rehabilitation, with improvements in 6MWD, quality of life, and self-efficacy,so it is expected to become a new and effective alternative mode of pulmonary rehabilitation.